Assessment of Digital and Clinical Workflow Using Patient Specific Sticky Bone /Implant Housing PEEK Shell in Anterior Atrophic Maxilla: A Case Series
Ridge Augmentation
About this trial
This is an interventional treatment trial for Ridge Augmentation
Eligibility Criteria
Inclusion Criteria: Patients with Multiple missing Maxillary Anterior Teeth with horizontally defective ridges having adequate soft tissue ample. Patients who already gave their consent for this trial. Males and females both will be included. Exclusion Criteria: Patients on bisphosphonates or drugs altering bone metabolism, within 2 months before initiating the study. Subjected to irradiation in the head and neck region within the last year Patients allergic to drugs used in the study like ( Articaine, Lidocaine, Patients having a history of a major medical condition (ASA 3,4) Untreated periodontitis. Poor oral hygiene and motivation. Uncontrolled diabetes. Pregnant or nursing. Substance abuse. Psychiatric problems or unrealistic expectations. Severe bruxism or clenching. Immunosuppressed or immunocompromised. Treated or under treatment with intravenous amino-bisphosphonates. Active infection or severe inflammation in the area intended for implant placement. Unable to open mouth sufficiently to accommodate the surgical tooling. Patients participating in other studies, if the present protocol could not be properly followed. Referred only for implant placement or unable to attend a 5-year follow-up.
Sites / Locations
- Faculty of Dentistry, Cairo UniversityRecruiting
Arms of the Study
Arm 1
Other
Augmented group
Patient Specific Sticky Bone /Implant Housing PEEK Shell in Anterior Atrophic Maxilla with simultaneous implant placement